Diabetes Drug Actos Under Review

by Savitha C Muppala on  June 19, 2011 at 10:30 PM Diabetes News
RSS Email Print This Page Comment bookmark
Font : A-A+

Recent reports about the risk of bladder cancer with the diabetes drug pioglitazone, has raised concern and Health Canada is reviewing the status of the drug.
 Diabetes Drug Actos Under Review
Diabetes Drug Actos Under Review

Pioglitazone, which is marketed in Canada under the brand name Actos as well as in generic forms, is prescribed both ways- in combination with other diabetes drugs or exclusively, especially when lifestyle changes like diet and exercise have done little to control blood sugar.

The federal department has confirmed that the safety of this drug is being monitored. Health Canada said that the advantages of consuming pioglitazone is much more than the perceived risks .



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Diabetic Retinopathy Drug Toxicity Diabetes Diabetic Diet Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Signature Drug Toxicity Stress Relief Through Alternative Medicine 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive